Aleksandra Stanczak
Kazun Nowy, MZ 05152, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Identification of pyrrolo[2,3-d]pyrimidine-based dual MERTK and FLT3 inhibitor: Hit-to-lead, machine learning, modeling, synthesis, and biological evaluation.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: October 31, 2025
Preclinical characterization of CPL304110 as a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3 for gastric, bladder, and squamous cell lung cancer.
Journal: Frontiers in oncology
Published: September 13, 2023
FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer.
Journal: International journal of molecular sciences
Published: July 28, 2022
Design, Synthesis, and Development of Pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part II-Benzimidazole Derivatives.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 22, 2022
Design, Synthesis, and Development of pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part I-Indole Derivatives.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 22, 2022
p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer.
Journal: Cells
Published: October 28, 2021
MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells.
Journal: Frontiers in oncology
Published: November 25, 2020
Discovery and optimization of novel pyrazole-benzimidazole CPL304110, as a potent and selective inhibitor of fibroblast growth factor receptors FGFR (1-3).
Journal: European journal of medicinal chemistry
Published: August 26, 2020
Differences in gene expression and alterations in cell cycle of acute myeloid leukemia cell lines after treatment with JAK inhibitors.
Journal: European journal of pharmacology
Published: April 19, 2015
Cell-based assay for low- and high-scale screening of the Wnt/β-catenin signaling modulators.
Journal: Analytical biochemistry
Published: October 11, 2014
Epithelial-mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: June 24, 2014
Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer.
Journal: Journal of ovarian research
Published: November 05, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026